ATE531363T1 - Behandlung und prävention von übermässiger narbenbildung - Google Patents

Behandlung und prävention von übermässiger narbenbildung

Info

Publication number
ATE531363T1
ATE531363T1 AT07788039T AT07788039T ATE531363T1 AT E531363 T1 ATE531363 T1 AT E531363T1 AT 07788039 T AT07788039 T AT 07788039T AT 07788039 T AT07788039 T AT 07788039T AT E531363 T1 ATE531363 T1 AT E531363T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
excessive scaring
scaring
excessive
Prior art date
Application number
AT07788039T
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Elisabeth Lenestour
Jay Bua
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Priority claimed from PCT/EP2007/057838 external-priority patent/WO2008015190A2/en
Application granted granted Critical
Publication of ATE531363T1 publication Critical patent/ATE531363T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT07788039T 2006-07-31 2007-07-30 Behandlung und prävention von übermässiger narbenbildung ATE531363T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83416306P 2006-07-31 2006-07-31
EP06291239A EP1891945A1 (de) 2006-07-31 2006-07-31 Behandlung und Prävention von übermässiger Narbenbildung
PCT/EP2007/057838 WO2008015190A2 (en) 2006-07-31 2007-07-30 Treatment and prevention of excessive scarring

Publications (1)

Publication Number Publication Date
ATE531363T1 true ATE531363T1 (de) 2011-11-15

Family

ID=37453247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788039T ATE531363T1 (de) 2006-07-31 2007-07-30 Behandlung und prävention von übermässiger narbenbildung

Country Status (3)

Country Link
EP (1) EP1891945A1 (de)
AT (1) ATE531363T1 (de)
ES (1) ES2376865T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103041012A (zh) * 2013-01-29 2013-04-17 刘婷 用于祛除增生凸疤疙瘩的中药组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US7767717B2 (en) * 2003-06-09 2010-08-03 Ascend Therapeutics, Inc. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
ES2376865T3 (es) 2012-03-20
EP1891945A1 (de) 2008-02-27

Similar Documents

Publication Publication Date Title
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EP2493464A4 (de) Methylsulfonylmethan (msm) zur behandlung wirkstoffresistenter mikroorganismen
ATE460164T1 (de) Mittel zur behandlung von hyperlipidämie mit pitavastatinen und eicosapentaensäure
BRPI1012219B8 (pt) produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
EA201390707A1 (ru) Способ лечения контраст-индуцированной нефропатии
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
ECSP088762A (es) Tratamiento del dolor
CY1111519T1 (el) Χρηση των παραγωγων σουλφαμιδιου βενζο-συντηγμενου ετεροκυκλου για την αγωγη της μανιας και της διπολικhς διαταραχhς
BR112012006891A2 (pt) formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo
EA200801997A1 (ru) Новые соединения
EA200700074A1 (ru) Способ повышения скорости заживления повреждения ( варианты ), устройство доставки перекиси водорода и композиция для лечения повреждений у млекопитающих
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
ATE462438T1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
BR112012015433B8 (pt) composição farmacêutica substancialmente anidra para aplicação cutânea
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
WO2018094023A3 (en) Cyclic dipeptides and wound healing
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
EA200870089A1 (ru) Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции
MA30620B1 (fr) Carboxamides substitues
ATE393625T1 (de) Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
CL2009000065A1 (es) Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.
WO2008015190A3 (en) Treatment and prevention of excessive scarring